Search results
Stellantis extends preventive recall to other models over airbag worries By Reuters
Investing.com· 53 minutes agoCar maker Stellantis (NYSE:STLA) has preventively extended a recall of vehicles with potentially...
Silicon Valley is warming up to Donald Trump
Business Insider via Yahoo News· 1 hour agoDavid Sacks and Chamath Palihapitiya may have been aiming to shift the narrative on Trump support. The event raised around $12 million, Reuters reported,...
Ukraine’s winter crops to ripen earlier due to unusually warm weather
WHTC 1450 Holland· 3 hours agoKYIV (Reuters) - Winter grain crops in Ukraine will ripen at least two weeks earlier than usual due...
Trump tells Dr Phil taking revenge on political opponents ‘can be justified’ in wild interview: Live...
The Independent via Yahoo News· 31 minutes agoOur troops deserve our respect and support—both on and off the battlefield. Trump doesn’t understand...
UN chief to call out Israel for violations against children
Reuters via AOL· 2 hours agoNEW YORK (Reuters) -United Nations Secretary-General Antonio Guterres has added Israel's military to...
New York Times, Reuters staff battle with news union after radical Guild rep makes controversial...
Fox News via Yahoo News· 3 hours agoStaffers at The New York Times and Reuters are publicly fighting with the influential NewsGuild of...
Analysis-Mexico investors worry lopsided vote could threaten rule of law By Reuters
Investing.com· 3 hours agoNEW YORK/MEXICO CITY (Reuters) -The Mexican governing party's unexpectedly lopsided victory this...
Hunter Biden's ex-girlfriend 'panicked' after finding gun
BBC via AOL· 3 hours agoHallie Biden photographed arriving at Hunter Biden's trial on Thursday with her husband [Reuters]...
European shares extend losses as hot US payrolls flare rate worries
WSAU Wausau· 47 minutes agoBy Shristi Achar A and Shashwat Chauhan (Reuters) - European shares extended losses on Friday,...
J&J-backed Rapport Therapeutics valued at $636.8 million after shares rise 6% in debut
WHTC 1450 Holland· 2 hours ago(Reuters) - Shares of Rapport Therapeutics, backed by Johnson & Johnson's venture capital arm, rose nearly 6% in their market debut on Friday, valuing the early stage therapy ...